Zijlstra JG - Search Results

1

Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.

de Jong S, Zijlstra JG, Mulder NH, de Vries EG. de Jong S, et al. Among authors: zijlstra jg. Cancer Chemother Pharmacol. 1991;28(6):461-4. doi: 10.1007/BF00685823. Cancer Chemother Pharmacol. 1991. PMID: 1657425

2

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.

van der Zee AG, Hollema H, de Jong S, Boonstra H, Gouw A, Willemse PH, Zijlstra JG, de Vries EG. van der Zee AG, et al. Among authors: zijlstra jg. Cancer Res. 1991 Nov 1;51(21):5915-20. Cancer Res. 1991. PMID: 1682037

3

Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.

de Jong S, Zijlstra JG, de Vries EG, Mulder NH. de Jong S, et al. Among authors: zijlstra jg. Cancer Res. 1990 Jan 15;50(2):304-9. Cancer Res. 1990. PMID: 1967222

4

Morpholinyl anthracyclines: option for reversal of anthracycline resistance.

de Vries EG, Zijlstra JG. de Vries EG, et al. Among authors: zijlstra jg. Eur J Cancer. 1990;26(6):659-60. doi: 10.1016/0277-5379(90)90110-f. Eur J Cancer. 1990. PMID: 2144150 Review. No abstract available.

5

Topoisomerases, new targets in cancer chemotherapy.

Zijlstra JG, de Jong S, de Vries EG, Mulder NH. Zijlstra JG, et al. Med Oncol Tumor Pharmacother. 1990;7(1):11-8. doi: 10.1007/BF03000485. Med Oncol Tumor Pharmacother. 1990. PMID: 2160032 Review.

6

Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell lines.

Zijlstra JG, de Vries EG, Muskiet FA, Martini IA, Timmer-Bosscha H, Mulder NH. Zijlstra JG, et al. Int J Cancer. 1987 Dec 15;40(6):850-6. doi: 10.1002/ijc.2910400625. Int J Cancer. 1987. PMID: 2826341

7

Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay.

de Jong S, Zijlstra JG, Timmer-Bosscha H, Mulder NH, de Vries EG. de Jong S, et al. Among authors: zijlstra jg. Int J Cancer. 1986 Apr 15;37(4):557-61. doi: 10.1002/ijc.2910370414. Int J Cancer. 1986. PMID: 3007375

8

Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.

Zijlstra JG, de Jong S, van de Grampel JC, de Vries EG, Mulder NH. Zijlstra JG, et al. Cancer Res. 1986 Jun;46(6):2726-9. Cancer Res. 1986. PMID: 3008999

9

Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.

Zijlstra JG, de Vries EG, Mulder NH. Zijlstra JG, et al. Cancer Res. 1987 Apr 1;47(7):1780-4. Cancer Res. 1987. PMID: 3028613

10

Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.

Zijlstra JG, Meijer C, Timmer-Bosscha H, Le TK, de Vries EG, Mulder NH. Zijlstra JG, et al. Eur J Respir Dis Suppl. 1987;149:53-5. Eur J Respir Dis Suppl. 1987. PMID: 3034649 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters